Article
The splicing factor kinase SRPK1 is a therapeutic target for Peripheral Vascular Disease
2024-04-22
Abstract excerpt
<h4>Introduction</h4> In peripheral arterial disease (PAD) anti-angiogenic VEGF-A 165 b isoform overexpression in monocytes contributes to impaired collateralisation. Serine-arginine protein-kinase-1 (SRPK1) regulates VEGF splicing. To determine whether SRPK1 controlled monocytic VEGF, impairing collateralisation, we investigated SRPK1 inhibition and monocyte-specific knockout in mouse models of and in human mon...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fb000948-da86-5f64-8bb7-94df3cb01933
- DOI
- 10.1101/2024.04.17.589996
